NeoGenomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.

CEO

Anthony P. Zook

CEOAnthony P. Zook

Employees

2,200

Employees2,200

Headquarters

Fort Myers, Florida

HeadquartersFort Myers, Florida

Founded

1998

Founded1998

Employees

2,200

Employees2,200

NEO Key Statistics

Market cap

1.14B

Market cap1.14B

Price-Earnings ratio

-10.76

Price-Earnings ratio-10.76

Dividend yield

—

Dividend yield—

Average volume

2.45M

Average volume2.45M

High today

$9.04

High today$9.04

Low today

$8.44

Low today$8.44

Open price

$8.75

Open price$8.75

Volume

5.65M

Volume5.65M

52 Week high

$19.12

52 Week high$19.12

52 Week low

$4.72

52 Week low$4.72

NEO News

Benzinga 4d

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. NTRA assert...

TipRanks 4d

NeoGenomics announces court ruling in its favor in lawsuit against Natera

NeoGenomics (NEO) announced the District Court for the Middle District of North Carolina has granted NeoGenomics’ motion for summary judgment that all of Natera...

Analyst ratings

53%

of 15 ratings

Buy

40%

Hold

53.3%

Sell

6.7%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.